CORVERT

This brand name is authorized in United States. It is also authorized in Austria, Canada, Finland, Netherlands.

Active ingredients

The drug CORVERT contains one active pharmaceutical ingredient (API):

1	Ibutilide UNII 9L5X4M5L6I - IBUTILIDE FUMARATE
	Ibutilide is a Class III antiarrhythmic agent available in intravenous formulations. It is indicated for the conversion of acute atrial flutter and recent onset atrial fibrillation to normal sinus rhythm (NSR).
	Read more about Ibutilide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C01BD05	Ibutilide	C Cardiovascular system → C01 Cardiac therapy → C01B Antiarrhythmics, class I and III → C01BD Antiarrhythmics, class III
Discover more medicines within C01BD05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02242470
FI	Lääkealan turvallisuus- ja kehittämiskeskus	448944
NL	Z-Index G-Standaard	14143585
NL	Z-Index G-Standaard, PRK	101834
US	FDA, National Drug Code	0009-3794